Cigarette smoking costs an estimated 418,000 American lives annually. Cessation reduces this cost, but is difficult because smoking is maintained by factors such as withdrawal, tobacco's direct effects, and smoking-related stimuli. Current cessation methods address these factors: nicotine replacement treatments (NRTs) suppress withdrawal and/or blunt the effects of cigarettes. Behavioral treatments reduce the influence of smoking-related stimuli. Nonetheless, about 70 percent of smokers who try to quit, fail. Improving smoking cessation rates is a national priority that may be achieved by tailoring treatment to the separate needs of subgroups, such as men and women. Treatment studies demonstrate that current cessation techniques are less effective for women. There is no clear explanation for this difference, but it may involve a differential response NRT and/or smoking-related stimuli. For women, NRT may be less effective at suppressing withdrawal (Hypothesis 1) or blunting the effects of smoking during a quit attempt (Hypothesis 2). Women may also be more sensitive to smoking-related stimuli, such as the taste, sight, and smell of smoke (Hypothesis 3). These hypotheses can be examined efficiently in the clinical laboratory. Strengths of this setting include control over extraneous variables, repeated measure designs that yield dose effect curves, and validated tools for measuring puff topography, tobacco withdrawal, and the direct effects of nicotine and/or cigarettes. Three such studies are proposed. In each study, 64 men and 64 women who smoke will participate in 4 double blind, randomly ordered, 6.5-hour sessions. Objectively verified cigarette abstinence will be required before each session. Studies 1 and 2 will compare, in men and women, the NRT dose response functions for suppression of tobacco and blunting the effects of cigarettes; study 3 will compare the effects of smoking-related stimuli. Thus hypotheses 1, 2, and 3 are each addressed in separate studies. Overall, this project may improve cessation interventions for all smokers, particularly women. Given the costs of smoking and the dramatic reduction in these costs when smokers quit smoking, improving the treatment options for all smokers is essential.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011082-07
Application #
6623771
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Montoya, Ivan
Project Start
1997-07-01
Project End
2007-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
7
Fiscal Year
2003
Total Cost
$375,000
Indirect Cost
Name
Virginia Commonwealth University
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Kleykamp, Bethea A; Jennings, Janine M; Eissenberg, Thomas (2011) Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers. Exp Clin Psychopharmacol 19:75-84
Blank, Melissa D; Disharoon, Steven; Eissenberg, Thomas (2009) Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 11:896-903
Primack, Brian A; Sidani, Jaime; Agarwal, Aaron A et al. (2008) Prevalence of and associations with waterpipe tobacco smoking among U.S. university students. Ann Behav Med 36:81-6
Smith-Simone, Stephanie; Maziak, Wasim; Ward, Kenneth D et al. (2008) Waterpipe tobacco smoking: knowledge, attitudes, beliefs, and behavior in two U.S. samples. Nicotine Tob Res 10:393-8
Eissenberg, Thomas; Ward, Kenneth D; Smith-Simone, Stephanie et al. (2008) Waterpipe tobacco smoking on a U.S. College campus: prevalence and correlates. J Adolesc Health 42:526-9
Blank, Melissa D; Kleykamp, Bethea A; Jennings, Janine M et al. (2007) Caffeine's influence on nicotine's effects in nonsmokers. Am J Health Behav 31:473-83
Evans, Sarah E; Blank, Melissa; Sams, Cynthia et al. (2006) Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol 14:121-35
Ward, Kenneth D; Hammal, Fadi; VanderWeg, Mark W et al. (2005) Are waterpipe users interested in quitting? Nicotine Tob Res 7:149-56
Maziak, W; Ward, K D; Afifi Soweid, R A et al. (2004) Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control 13:327-33
Maziak, W; Ward, K D; Eissenberg, T (2004) Factors related to frequency of narghile (waterpipe) use: the first insights on tobacco dependence in narghile users. Drug Alcohol Depend 76:101-6

Showing the most recent 10 out of 11 publications